SPDR Series Trust SPDR S&P Biotech ETF (XBI)
$88.25
0.44 (0.50%)
XBI Stock Quote Delayed 30 Minutes
SPDR S&P Biotech (ETF) (XBI): Embrace the Biotech Bulls’ Return
Strength is returning anew to biotech stocks. Embrace the sector with a play on XBI to capitalize on further gains.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
58.09M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
7.27M
Day's Range
$87.84 - $89.83
52-Week Range
$81.14 - $105.47
Dividend & Yield
$0.03 (0.03%)
XBI Stock Predictions, Articles, and SPDR Series Trust SPDR S&P Biotech ETF News
SPDR S&P Biotech (ETF) (XBI) – The Best Biotech Investment Now
The best biotech stocks are hard to identify, but the XBI ETF allows investors to make a diversified but aggressive bet on small, high-growth biotech stocks.
IBB: Another Biotech Bloodbath Beckons
Biotech stocks are poised for another downturn. Profit with this IBB stock put spread.
Why Now Is the Time to Pile Back Into Biotech Stocks (IBB, XBI)
For years, biotech stocks have outperformed the market. In light of their recent downturn, now's a fine time to buy biotech ETFs like IBB and XBI.
Bet on a Bounce with These Biotech ETFs
Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain.
Be Careful Before Loving Leveraged Biotech ETFs
The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs.
Biotech Stocks: Is It Safe to Come out Now? (IBB, XBI)
Biotech stocks are getting smashed this week, but betting against the sector remains a bad idea. The only trick is getting the timing right.
The Best Way to Buy Biotech Stocks: A Heated Debate
Among ETFs that hold biotech stocks, XBI looks like a winner, holding the advantages of equal-weighting and exposure to some potential highfliers.
Biotech Stocks Set to Soar, So Buy This Top Biotech ETF
Biotech stocks are NOT in a bubble, and the XBI biotech ETF is a cheap and diversified way to play the long-term potential of biotechnology.
XBI – Your Best ETF to Buy Now
The XBI biotech ETF is your best way to tap into the growth of healthcare and the stability of a good, cheap exchange traded fund.
5 Best ETFs to Buy Right Now
If you want to beat the market, check out these five best ETFs across several different investment flavors.
Biotech ETFs – Keep Those Buyouts Coming!
Merck's buyout of Idenix didn't just pump up IDIX shares -- it also had a great double effect on biotech ETFs such as XBI that usually are buoyed by M&A.
